Literature DB >> 22750564

Radiosynthesis of a ⁶⁸Ga labeled matrix metalloproteinase inhibitor as a potential probe for PET imaging.

Michael Claesener1, Otmar Schober, Stefan Wagner, Klaus Kopka.   

Abstract

A matrix metalloproteinase inhibitor based on a barbiturate scaffold was conjugated with a cyclooctyne derivative of the (radio)metal chelator DOTA via strain induced azide alkyne cycloaddition. Subsequent radiolabeling with (68)Ga yielded the corresponding radiometal labeled target compound (68)Ga-4 with a yield of 87% (decay corrected). The target molecule was also synthesized by a second synthesis route, the reaction of a pre-labeled (68)Ga-cyclooctyne-DOTA derivative (68)Ga-1 with an azide bearing barbiturate 3. This approach offers a valuable alternative for providing the desired (68)Ga-radiolabeled target compound. But, in this case, the strain induced cycloaddition of the reported pre-labeled cyclooctyne-DOTA derivative (68)Ga-1 with azides was proven to be slow at room temperature and heating was necessary for acceptable reaction times.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750564     DOI: 10.1016/j.apradiso.2012.04.013

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

1.  Towards Optimized Bioavailability of 99mTc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity.

Authors:  Lisa Honold; Melanie Austrup; Andreas Faust; Christian Paul Konken; Katrin Schwegmann; Bastian Zinnhardt; Constantin Gabriel Daniliuc; Günter Haufe; Michael Schäfers; Klaus Kopka; Sven Hermann
Journal:  Mol Imaging Biol       Date:  2021-11-08       Impact factor: 3.484

2.  Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases.

Authors:  Hans-Jörg Breyholz; Klaus Kopka; Michael Schäfers; Stefan Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2017-05-30

Review 3.  Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).

Authors:  Loganathan Rangasamy; Bruno Di Geronimo; Irene Ortín; Claire Coderch; José María Zapico; Ana Ramos; Beatriz de Pascual-Teresa
Journal:  Molecules       Date:  2019-08-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.